No more Mr. Niceguy. It started as “better guidance” for prescribers as concerns mounted that the over-prescription of opioid pain medications was feeding a sharp rise in addiction to illicit forms, including street-sourced pills and heroin. But it has turned into well-coordinated federal and state enforcement actions against physicians and nurses, as well as their practices and hospitals where they practice. Here are the key lessons The Greeley Company has learned from performing external peer review of pain management cases.
Editor’s Note: the blog post originally appeared on The Greeley Company’s website.
To view the full blog post, please click here.
News from our Partners
